Tumor Biology

, Volume 35, Issue 8, pp 7393–7396 | Cite as

Refute the conclusion made by Jie et al. in “Prognostic role of microRNA-100 in various carcinomas: evidence from six studies”

  • Dali Chen
  • Yubin Zhou
  • Heng Du
  • Guowei Che
Research Commentary


Recently, we had the honor of reading a meta-analysis article published in Tumor Biology which was completed by Jie et al. Because of our interest in the correlations between microRNAs (miRs) and human cancer prognosis, we carefully read the entire article. Jie et al. put forward a standpoint that deregulation of miR-100 in cancerous tissues could significantly predict poor survival in various carcinomas. The pooled hazard ratio (HR) with 95 % confidence interval (CI) was 2.19 (1.49–3.24, p = 0.0007). The reliability of the meta-analysis is reciprocally higher than traditional and narrative reviews. Furthermore, the reliability is exclusively dependent on reference retrieval, incorporating eligible articles as comprehensive as possible, and proper and accurate data extraction. We found several critical errors in their meta-analysis, and its conclusion was unbelievable and might misguide readers. According to their statistical strategies, we also conducted a meta-analysis to reevaluate the relationship between deregulation of miR-100 and human cancer prognosis for rectification. The present studies are not powerful enough to demonstrate the prognostic role of miR-100 in human cancers, and thus, much more works are needed in this field.


MicroRNA-100 Human cancers Prognosis Meta-analysis 


Conflicts of interest



  1. 1.
    Chen J, Zheng B, Wang C, Chen Y, Du C, Zhao G et al. Prognostic role of microRNA-100 in various carcinomas: evidence from six studies. Tumour Biol. 2013 [Epub ahead of print]Google Scholar
  2. 2.
    Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, et al. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer. 2012;12:369. doi: 10.1186/1471-2407-12-369.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One. 2012;7(3):e33762. doi: 10.1371/journal.pone.0033762.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Peng DX, Luo M, Qiu LW, He YL, Wang XF. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Oncol Rep. 2012;27(4):1238–44.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Feber A, Xi L, Pennathur A, Gooding WE, Bandla S, Wu M, et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg. 2011;91(5):1523–30.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Wang S, Xue S, Dai Y, Yang J, Chen Z, Fang X, et al. Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer. Diagn Pathol. 2012;7:159.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer. 2012;12:519.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Bai J, Guo A, Hong Z, Kuai W. Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia. Onco Targets Ther. 2012;5:213–9.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Wang G, Chen L, Meng J, Chen M, Zhuang L, Zhang L. Overexpression of microRNA-100 predicts an unfavorable prognosis in renal cell carcinoma. Int Urol Nephrol. 2013;45(2):373–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Chen P, Zhao X, Ma L. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem. 2013;383(1–2):49–58.PubMedCrossRefGoogle Scholar
  11. 11.
    Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Saudo A, Dall'Oglio MF, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J Urol. 2011;185(3):1118–22.PubMedCrossRefGoogle Scholar
  12. 12.
    Wang T, Lv M, Shen S, Zhou S, Wang P, Chen Y, et al. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS One. 2012;7(8):e43268. doi: 10.1371/journal.pone.0043268.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Department of Thoracic Surgery, West China HospitalSichuan UniversityChengduChina

Personalised recommendations